Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 May 21;64(6):e00483-20.
doi: 10.1128/AAC.00483-20. Print 2020 May 21.

Updated Approaches against SARS-CoV-2

Affiliations
Review

Updated Approaches against SARS-CoV-2

Haiou Li et al. Antimicrob Agents Chemother. .

Abstract

Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lies behind the ongoing outbreak of coronavirus disease 2019 (COVID-19). There is a growing understanding of SARS-CoV-2 in virology, epidemiology, and clinical management strategies. However, no anti-SARS-CoV-2 drug or vaccine has been officially approved due to the absence of adequate evidence. Scientists are racing to develop a treatment for COVID-19. Recent studies have revealed many attractive therapeutic options, even if some of them remain to be further confirmed in rigorous preclinical models and clinical trials. In this minireview, we aim to summarize the updated potential approaches against SARS-CoV-2. We emphasize that further efforts are warranted to develop the safest and most effective approach.

Keywords: COVID-19; SARS-CoV-2; antiviral drugs; treatment; vaccines.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Updated potential approaches against SARS-CoV-2. (A) Dampening of SARS-CoV-2 fusion/entry; disruption of SARS-CoV-2 replication; inhibition of excessive inflammatory response. (B) Convalescent plasma treatment. (C) Vaccines. (D) Combinations of traditional Chinese and Western medicine. ACE2, angiotensin-converting enzyme 2; rhACE2, recombinant human ACE2; HR2P, heptad repeat 2-derived peptides; EK1, a modified OC43-HR2P peptide; 3CLpro, 3C-like protease; RdRps, RNA-dependent RNA polymerases; AAV, adeno-associated virus; IL-6, interleukin-6; TCM, traditional Chinese medicine.

References

    1. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS, China Medical Treatment Expert Group for Covid-19 28 February 2020, posting date Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med doi: 10.1056/NEJMoa2002032. - DOI - PMC - PubMed
    1. World Health Organization. 2020. Coronavirus disease 2019 (COVID-19) situation report—53. https://www.who.int/docs/default-source/coronaviruse/situation-reports/2.... Accessed 13 March 2020.
    1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W; China Novel Coronavirus Investigating and Research Team . 2020. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382:727–733. doi: 10.1056/NEJMoa2001017. - DOI - PMC - PubMed
    1. Tian X, Li C, Huang A, Xia S, Lu S, Shi Z, Lu L, Jiang S, Yang Z, Wu Y, Ying T. 2020. Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. Emerg Microbes Infect 9:382–385. doi: 10.1080/22221751.2020.1729069. - DOI - PMC - PubMed
    1. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, Xing X, Xiang N, Wu Y, Li C, Chen Q, Li D, Liu T, Zhao J, Li M, Tu W, Chen C, Jin L, Yang R, Wang Q, Zhou S, Wang R, Liu H, Luo Y, Liu Y, Shao G, Li H, Tao Z, Yang Y, Deng Z, Liu B, Ma Z, Zhang Y, Shi G, Lam TTY, Wu JTK, Gao GF, Cowling BJ, Yang B, Leung GM, Feng Z. 29 January 2020, posting date Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med doi: 10.1056/NEJMoa2001316. - DOI - PMC - PubMed

LinkOut - more resources